Header Logo

Connection

Sally Kent to Carcinogens

Back to Details
This is a "connection" page, showing publications Sally Kent has written about Carcinogens.
Sally Kent
Connection Strength
0.016
Carcinogens
  1. Quintana FJ, Gerber D, Kent SC, Cohen IR, Shai Y. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest. 2005 Aug; 115(8):2149-58.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.